Literature DB >> 29181184

Claudin-1 expression in cervical cancer.

Friederike Hoellen1, Annika Waldmann2, Constanze Banz-Jansen3, Uwe Holtrich4, Thomas Karn4, Martina Oberländer5,6, Jens K Habermann5,6, Mareike Hörmann7, Frank Köster1, Julika Ribbat-Idel8, Marc Thill9, Achim Rody1, Ahmed El-Balat4, Lars Hanker1.   

Abstract

Claudin-1 is a tight junction protein that has been demonstrated to be involved in tumorigenesis and tumor progression in various types of solid tumors. In the present study, the protein expression of claudin-1 in squamous cervical cancer tissues obtained from 106 patients was analyzed by immunohistochemistry. In addition, the grade of claudin-1 expression was analyzed for associations with certain clinicopathological parameters. A significant overexpression of claudin-1 was detected in the tumor cells, when compared with that in the peritumoral stroma. There was no significant association between claudin-1 expression and FIGO stage, tumor size, grading or the appearance of distant metastases. Cervical cancer patients scoring positive for claudin-1 protein expression tended to exhibit more lymph node metastasis (28.3%), compared with claudin-1-negative patients (7.1%). Regarding overall survival, the results of the present study suggest a better prognosis for claudin-1-negative patients. In order to elucidate whether claudin-1 overexpression has a significant prognostic impact on squamous cervical cancer, further studies are required.

Entities:  

Keywords:  cervical cancer; claudin-1; immunohistochemistry; lymph node metastases; squamous cervical cancer; survival analysis

Year:  2017        PMID: 29181184      PMCID: PMC5700277          DOI: 10.3892/mco.2017.1391

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  11 in total

1.  [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

Authors:  W Remmele; H E Stegner
Journal:  Pathologe       Date:  1987-05       Impact factor: 1.011

2.  Claudin-1 as a Biomarker of Cervical Cytology and Histology.

Authors:  Márta Benczik; Ádám Galamb; Róbert Koiss; Attila Kovács; Balázs Járay; Tamás Székely; Tímea Szekerczés; Zsuzsa Schaff; Gábor Sobel; Csaba Jeney
Journal:  Pathol Oncol Res       Date:  2016-01       Impact factor: 3.201

3.  A 'waterfall' transfer-based workflow for improved quality of tissue microarray construction and processing in breast cancer research.

Authors:  M Oberländer; H Alkemade; S Bünger; F Ernst; C Thorns; T Braunschweig; J K Habermann
Journal:  Pathol Oncol Res       Date:  2014-03-07       Impact factor: 3.201

Review 4.  Claudins: emerging targets for cancer therapy.

Authors:  Scott L Kominsky
Journal:  Expert Rev Mol Med       Date:  2006-08-04       Impact factor: 5.600

5.  The role of claudin-1 and claudin-7 in cervical tumorigenesis.

Authors:  Ciaran Cunniffe; Brenda Brankin; Helen Lambkin; Fergus Ryan
Journal:  Anticancer Res       Date:  2014-06       Impact factor: 2.480

Review 6.  Role of claudins in tumorigenesis.

Authors:  Karen Swisshelm; Robert Macek; Manfred Kubbies
Journal:  Adv Drug Deliv Rev       Date:  2005-04-25       Impact factor: 15.470

Review 7.  Claudins as diagnostic and prognostic markers in gynecological cancer.

Authors:  I Szabó; A Kiss; Z Schaff; G Sobel
Journal:  Histol Histopathol       Date:  2009-12       Impact factor: 2.303

8.  Expression of tight and adherens junction proteins in cervical neoplasia.

Authors:  C Cunniffe; F Ryan; H Lambkin; B Brankin
Journal:  Br J Biomed Sci       Date:  2012       Impact factor: 3.829

Review 9.  Emerging roles of claudins in human cancer.

Authors:  Mi Jeong Kwon
Journal:  Int J Mol Sci       Date:  2013-09-04       Impact factor: 5.923

10.  CLDN1 expression in cervical cancer cells is related to tumor invasion and metastasis.

Authors:  Wei-Na Zhang; Wei Li; Xiao-Li Wang; Zheng Hu; Da Zhu; Wen-Cheng Ding; Dan Liu; Ke-Zhen Li; Ding Ma; Hui Wang
Journal:  Oncotarget       Date:  2016-12-27
View more
  3 in total

1.  E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.

Authors:  Perla Yaceli Uc; Jael Miranda; Arturo Raya-Sandino; Lourdes Alarcón; María Luisa Roldán; Rodolfo Ocadiz-Delgado; Enoc Mariano Cortés-Malagón; Bibiana Chávez-Munguía; Georgina Ramírez; René Asomoza; Liora Shoshani; Patricio Gariglio; Lorenza González-Mariscal
Journal:  Int J Oncol       Date:  2020-07-29       Impact factor: 5.650

2.  Synergetic Effects of Intronic Mature miR-944 and ΔNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line.

Authors:  Jungho Kim; Sunyoung Park; Yunhee Chang; Kwang Hwa Park; Hyeyoung Lee
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

3.  Response to Comment on "Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis".

Authors:  Jung-Soo Pyo; Nae Yu Kim; Won Jin Cho
Journal:  J Pathol Transl Med       Date:  2019-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.